Elsevier

Brain Research

Volume 709, Issue 2, 19 February 1996, Pages 285-295
Brain Research

Research report
Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies

https://doi.org/10.1016/0006-8993(95)01325-3Get rights and content

Abstract

Dopamine-derived 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol, Sal) and related compounds were examined for their selective neurotoxicity to dopamine neurons by injection into the rat striatum. Among salsolinol analogs examined, only N-methyl-(R)-salsolinol (NM(R)Sal) induced behavioral changes very similar to those in Parkinson's disease: hypokinesia, stiff tail, limb twitching at rest and postural abnormality. Biochemical analysis showed that after NM(R)Sal injection, NM(R)Sal itself and its oxidation product, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion (DMDHIQ+) accumulated in the striatum, and also in the substantia nigra definite amount of DMDHIQ+ was detected. Dopamine and noradrenaline were reduced in the striatum and more markedly in the substantia nigra, whereas serotonin and its metabolite were not affected. Morphological analysis revealed selective reduction of tyrosine hydroxylase (TH)-containing neurons in the substantia nigra after continuous NM(R)Sal administration in the striatum. These results demonstrate the selective cytotoxicity of NM(R)Sal to the dopamine neurons in the substantia nigra, and the possible involvement of this 6,7-dihydroxyisoquinoline in the pathogenesis of Parkinson's disease is discussed.

References (39)

  • T. Nagatsu et al.

    An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions

    Neurosci. Lett.

    (1988)
  • M. Naoi et al.

    Simple assay procedure for tyrosine hydroxylase activity by high-performance liquid cbromatography employing coulometric detection with minimal sample preparation

    J. Chromatogr.

    (1988)
  • M. Naoi et al.

    Binding of 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion to melanin: effects of ferrous and ferric ion on the binding

    Neurosci. Lett.

    (1994)
  • M. Naoi et al.

    Dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines; oxidation and neurotoxicity

    Prog. Brain Res.

    (1995)
  • M. Naoi et al.

    Enzymatic oxidation of the dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1, 2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion

    Life Sci.

    (1995)
  • A. Nitta et al.

    Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats

    Neuroscience

    (1993)
  • T. Niwa et al.

    Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroiso-quinoline and 1,2-dimethyl-6,7-dihy droxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains

    Biochem. Biophys. Res. Commun.

    (1991)
  • A. Ota et al.

    The effect of a heterocyclic amine, 3-amino-1,4-dimethyl-5Hpyrido(4,3-b)indole (Trp-P-1), on tyrosine hydroxylase mRNA in PC12h cells

    Neurosci. Lett.

    (1993)
  • K. Suzuki et al.

    Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mito chondria prepared from mouse brain

    J. Neurol. Sci.

    (1992)
  • Cited by (0)

    View full text